- Scale up
- Process evaluations
- Feasibility studies on both technical and economic aspects
- Technical Due diligence and site evaluations
- Process simulations
- Containments considering biosafety levels 1 to 3 (BSL 1 3)
For some decades now, production capacities for biopharmaceutical products, mostly antibodies, have been limited. Production capacities are therefore being expanded worldwide. In addition, new, patient-based therapies, such as stem cell or car-T cell therapies, require new production capacities.
Whether microbial large-scale production of small molecules in bioreactors of 5 - 100 m3 or cell culture-based production in Singel Use Technology, our interdisciplinary team will support you in the planning of your production plant. In addition, we can draw on our know-how from successfully implemented projects.
Chemgineering assists your design projects with a well-trained team of specialists.
Chemgineering assists your design projects with a well-trained team of specialists.
Upstream processing (USP) and downstream processing (DSP) plants were designed either traditionally in stainless steel or for implementing Single Use Technology (SUT) including the impact of SUT on warehousing and building and site logistics.
This website uses cookies to provide you with the best possible experience. If you continue to browse our site, you consent to our use of cookies and to our privacy policy.